Treatment mediated by viral vector: Zhou et al. created an adenoviral vector carrying the miR-122 MRE to limit TRAIL expression in esophagus cancer cells and stop TRAIL action in liver tissues. This evidence concerns the gene TNFSF10 and esophageal cancer.